本试验旨在分析大通牦牛(Bos grunniens)ApoA1基因的分子特征,并检测其在不同组织的表达规律,为进一步研究ApoA1基因的功能提供理论依据。试验以牦牛肝脏cDNA为模板,通过PCR扩增和基因克隆获得牦牛ApoA1基因编码区序列(coding region se...本试验旨在分析大通牦牛(Bos grunniens)ApoA1基因的分子特征,并检测其在不同组织的表达规律,为进一步研究ApoA1基因的功能提供理论依据。试验以牦牛肝脏cDNA为模板,通过PCR扩增和基因克隆获得牦牛ApoA1基因编码区序列(coding region sequence,CDS),并进行生物信息学分析;利用RT-qPCR技术检测ApoA1基因mRNA在心脏、肌肉、肝脏、脾脏、肺脏、肾脏、子宫角、脂肪和输卵管等组织中的mRNA表达水平。结果表明,大通牦牛ApoA1基因编码区序列长798 bp,编码265个氨基酸;ApoA1蛋白质的分子质量为30324.414 Da,理论等电点为5.71;蛋白质二级结构以α-螺旋(93.58%)为主;牦牛ApoA1蛋白为不稳定亲水蛋白,存在信号肽,为分泌蛋白,不存在跨膜结构域;牦牛ApoA1基因的核苷酸序列与黄牛相应序列相似度最高,同源性为99.64%;组织表达谱分析表明,ApoA1基因在大通牦牛不同组织中都表达,但在肝脏中表达量最高,显著高于其他组织(P<0.05)。这些结果为进一步研究大通牦牛ApoA1基因在大通牦牛结构和功能及牦牛肉品质性状的遗传改良提供理论基础。展开更多
为了解牛miR-2439-5p的生物学信息和初步探索其与宿主基因MRTFA(Myocardin related transcription factor A,心肌素相关转录因子A)是否存在互作功能,以及进一步了解牛miR-2439-5p的组织表达规律,利用物种间保守性分析、上游序列CpG岛分...为了解牛miR-2439-5p的生物学信息和初步探索其与宿主基因MRTFA(Myocardin related transcription factor A,心肌素相关转录因子A)是否存在互作功能,以及进一步了解牛miR-2439-5p的组织表达规律,利用物种间保守性分析、上游序列CpG岛分析、启动子预测、转录因子预测、靶基因预测、基因本体论富集分析和信号通路富集分析等生物信息学方法对miR-2439-5p进行"转录因子-miRNA-mRNA"调控网络预测,并进行组织表达谱分析。结果表明:1)miR-2439-5p是牛特异性miRNA、内含子miRNA和miRNA*(相对低表达miRNA);2)miR-2439-5p可能受C/EBPβ和RARα等转录因子调控,预测其共有621个靶基因,显著富集在AMPK信号通、mTOR信号通路和不饱和脂肪酸合成等信号通路;3)miR-2439-5p在28月龄郏县红牛的肾组织中相对高表达,与肌肉和背脂组织存在显著性差异(P<0.01);其在28月龄和牛的背脂组织中相对高表达,与肝和脾组织存在显著性差异(P<0.05);其在28月龄固原黄牛的各组织表达量无显著性差异(P>0.05)。综上,miR-2439-5p可能反馈调节宿主基因MRTFA,从而调控牛脂肪细胞分化,为进一步探究miR-2439-5p的功能和作用机制提供研究方向和理论依据。展开更多
Objective: We evaluated the value of using a panel of GC B-cell (CD10 and Bcl-6) and activation (MUM1, CD138 and Bcl-2) markers by immunohistochemistry to define prognosis in patients with diffuse large B-cell ly...Objective: We evaluated the value of using a panel of GC B-cell (CD10 and Bcl-6) and activation (MUM1, CD138 and Bcl-2) markers by immunohistochemistry to define prognosis in patients with diffuse large B-cell lymphoma (DLBCL). Methods: Two different models (Hans' and modified Chang's model) were applied on 136 de hove DLBCL patients. Median follow-up in all patients was 39 months (range 5-80 months). Results: According to Hans' model, patients with GCB had much better overall survival (5-year OS, 75%) than those with non-GCB (5-year OS, 52%) (Kaplan-Meier survival analysis, P 〈 0.05, log rank test). According to modified Chang's model, patients with group 1 had much better overall survival (5-year OS, 78%) than those with group 3 (5-year OS, 44%) while group 2 had no significant value compared with group 1 and group 3 in prognosis (Kaplan-Meier survival analysis, P 〈 0.05, log-rank test). Using multivariate Cox proportional hazards regression analysis, the international prognostic index scores (IPI), expression of CD138 and the expression pattern of modified Chang's model were independent prognostic indicators. Conclusion: Our results suggest that the expression patterns of the panel of GCB-cell and activation markers by immunohistochemistry correlate with prognosis of patients with DLBCL and both models can be used well in ordinary work.展开更多
文摘为了解牛miR-2439-5p的生物学信息和初步探索其与宿主基因MRTFA(Myocardin related transcription factor A,心肌素相关转录因子A)是否存在互作功能,以及进一步了解牛miR-2439-5p的组织表达规律,利用物种间保守性分析、上游序列CpG岛分析、启动子预测、转录因子预测、靶基因预测、基因本体论富集分析和信号通路富集分析等生物信息学方法对miR-2439-5p进行"转录因子-miRNA-mRNA"调控网络预测,并进行组织表达谱分析。结果表明:1)miR-2439-5p是牛特异性miRNA、内含子miRNA和miRNA*(相对低表达miRNA);2)miR-2439-5p可能受C/EBPβ和RARα等转录因子调控,预测其共有621个靶基因,显著富集在AMPK信号通、mTOR信号通路和不饱和脂肪酸合成等信号通路;3)miR-2439-5p在28月龄郏县红牛的肾组织中相对高表达,与肌肉和背脂组织存在显著性差异(P<0.01);其在28月龄和牛的背脂组织中相对高表达,与肝和脾组织存在显著性差异(P<0.05);其在28月龄固原黄牛的各组织表达量无显著性差异(P>0.05)。综上,miR-2439-5p可能反馈调节宿主基因MRTFA,从而调控牛脂肪细胞分化,为进一步探究miR-2439-5p的功能和作用机制提供研究方向和理论依据。
文摘Objective: We evaluated the value of using a panel of GC B-cell (CD10 and Bcl-6) and activation (MUM1, CD138 and Bcl-2) markers by immunohistochemistry to define prognosis in patients with diffuse large B-cell lymphoma (DLBCL). Methods: Two different models (Hans' and modified Chang's model) were applied on 136 de hove DLBCL patients. Median follow-up in all patients was 39 months (range 5-80 months). Results: According to Hans' model, patients with GCB had much better overall survival (5-year OS, 75%) than those with non-GCB (5-year OS, 52%) (Kaplan-Meier survival analysis, P 〈 0.05, log rank test). According to modified Chang's model, patients with group 1 had much better overall survival (5-year OS, 78%) than those with group 3 (5-year OS, 44%) while group 2 had no significant value compared with group 1 and group 3 in prognosis (Kaplan-Meier survival analysis, P 〈 0.05, log-rank test). Using multivariate Cox proportional hazards regression analysis, the international prognostic index scores (IPI), expression of CD138 and the expression pattern of modified Chang's model were independent prognostic indicators. Conclusion: Our results suggest that the expression patterns of the panel of GCB-cell and activation markers by immunohistochemistry correlate with prognosis of patients with DLBCL and both models can be used well in ordinary work.